Physician profile
Robert J Lanoue
NPI 1396744561
$2,285.72
in general payments reported to CMS, 2019-2025
18 companies · $677 in 2025
The $677 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.52 · 2021: $59.04 · 2022: $153 · 2023: $398 · 2024: $975 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,425 · Education: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,425.05 |
| Education | $625.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $625.00 | 2024 | Ultomiris |
| Abbvie INC. | $511.15 | 2022-2025 | |
| Eisai INC. | $292.25 | 2023-2025 | |
| Biogen, INC. | $169.81 | 2021-2025 | Tysabri, Vumerity, Leqembi |
| Amgen INC. | $165.01 | 2025 | Uplizna |
| Pfizer INC. | $75.58 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $67.38 | 2023-2025 | Austedo Xr, Austedo Xr |
| Averitas Pharma INC. | $62.06 | 2023-2024 | Qutenza |
| Lundbeck LLC | $60.10 | 2023-2024 | Vyepti |
| Inspire Medical Systems, INC. | $56.62 | 2023 | Inspire |
| Tg Therapeutics, INC. | $42.32 | 2025 | |
| Novartis Pharmaceuticals Corporation | $33.64 | 2022-2023 | |
| Genentech, INC. | $26.17 | 2024 | Ocrevus |
| Genentech USA, INC. | $24.66 | 2024 | Ocrevus |
| Genzyme Corporation | $23.52 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $20.67 | 2025 | Hizentra |
| Grt US Holding, INC. | $16.11 | 2022 | |
| Amneal Pharmaceuticals LLC | $13.67 | 2023 | Rytary |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lanoue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.